DoxorubicinAntibiotics, AntineoplasticInduction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsTaxoidsRadiotherapyCombined Modality TherapyCisplatinRadiotherapy DosageAntineoplastic AgentsCell Line, TumorTreatment OutcomeRadiotherapy, AdjuvantChemotherapy, AdjuvantDrug Resistance, NeoplasmRemission InductionBreast NeoplasmsDisease-Free SurvivalPaclitaxelApoptosisRadiotherapy, ConformalCaspase 12CyclophosphamideNeoplasm StagingSurvival AnalysisTumor Suppressor Protein p53Survival RateHead and Neck NeoplasmsNeoadjuvant TherapyLung NeoplasmsDrug Administration ScheduleCarcinoma, Squamous CellEtoposideFluorouracilVincristineRadiotherapy, High-EnergyNeoplasm Recurrence, LocalPrognosisAntineoplastic Agents, PhytogenicRadiotherapy, Intensity-ModulatedDose FractionationCarboplatinCarcinoma, Non-Small-Cell LungCardiomyopathiesVinblastineCytarabineDaunorubicinChemoradiotherapyIfosfamideDeoxycytidineDNA DamageNeoplasm MetastasisMitochondria, HeartRadiotherapy Planning, Computer-AssistedLeukemia, Myeloid, AcuteTumor Markers, BiologicalTime FactorsAdenocarcinomaFollow-Up StudiesDose-Response Relationship, DrugNasopharyngeal NeoplasmsGene Expression Regulation, NeoplasticHeartMethotrexateBleomycinRNA, Small InterferingSignal TransductionRNA, MessengerBrain NeoplasmsMyocardiumNeutropeniaTumor BurdenNeoplasmsKaplan-Meier EstimateSalvage TherapyRadiation InjuriesBone NeoplasmsHypopharyngeal NeoplasmsRetrospective StudiesLaryngectomyEnzyme InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaLaryngeal NeoplasmsMitoxantroneProspective StudiesInfusions, IntravenousAntimetabolites, AntineoplasticPrednisoneGranulocyte Colony-Stimulating FactorRadiotherapy, Computer-AssistedCranial IrradiationDisease ProgressionLeukopeniaLymphatic MetastasisRadiotherapy, Image-GuidedRadiation-Sensitizing AgentsIdarubicinAnthracyclinesTesticular NeoplasmsTransplantation, Autologous